medigraphic.com
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

2011, Number 2

<< Back Next >>

Rev Esp Med Quir 2011; 16 (2)

Closure of recurrent palate fistula with the use of plasma rich in growth factors

Jiménez BK, González SJG, Sahagún FJE

Language: Spanish
References: 10
Page: 119-123
PDF size: 301.63 Kb.


ABSTRACT

Palatal fistulas frequently occur as a complication of primary surgical closure of cleft palate, requiring, on average, three to four surgeries for correction. Due to the high rate of recurrence of this disease, and the resultant costs to health systems and risk of disability for patients, we decided to look for alternative methods of management with better chances of success. We considered that the use of plasma rich in growth factors would be a good option, which, although it has never been used in the closure of palatal fistulas, has been used successfully in maxillofacial surgery. We report the case of a 15-year-old male patient who had undergone surgery four times –without success– to close the palatal fistula. The patient was operated using plasma rich in growth factors, obtaining complete closure of the fistula and now, after two and a half years, there are not recurrences. We consider that the use of plasma rich in growth factors is a useful alterative in the treatment of palatal fistula closure that can offer advantages over conventional treatment.


REFERENCES

  1. Uemura T, et al. Oronasal fistula following cleft palate surgery in our institute of cleft lip palate during 12 years. J Jpn Cleft Palate Assoc 1994;19:100.

  2. Cohen SR, Kalinowski J, LaRossa D, Randall P. Cleft palate fistulas: a multivariate statistical analysis of prevalence, etiology, and surgical management. Plast Reconstr Surg 1991;87:1041-1047.

  3. Emory RE Jr., Clay R, Bite U, Jackson IT. Fistula formation and repair after palatal closure: an institutional perspective. Plast Reconstr Surg 1999;99:1535-1538.

  4. Smith DM, Vecchione L, Jiang S, Ford M, et al. The Pittsburgh Fistula Classification System: a standardized scheme for the description of palatal fistulas. Cleft Palate-Craniofac J 2007;44(6):590-594.

  5. Penna V, Bannasch H, Stark GB. The turbinate flap for oronasal fistula closure. Ann Plastic Surg 2007;59(6):679-681.

  6. Reyes M, Montero S, Cifuentes J, Zarzar E. Actualización de la técnica de obtención y uso del plasma rico en factores de crecimiento (PRGF). Revista Dental de Chile 2002;93(2):25-28.

  7. Méndez R, López L, Patiño B, Vázquez I y col. Plasma enriquecido en plaquetas en la alveoloplastia en pacientes fisurados. Cir Pediatr 2006;19(1):23-26.

  8. Jiménez MA, Angulo GJ, González HJ, Rodríguez CJM y col. La acromioplastia con reparación del manguito rotador y sus efectos en el test de Constant tras la aplicación de plasma rico en factores de crecimiento. Trauma Fund MAPFRE 2008;19(1):6-12.

  9. Sánchez M, Azofra J, Aizpurúa B, Elorriaga R y col. Aplicación de plasma autólogo rico en factores de crecimiento en cirugía artroscópica. Cuadernos de Artroscopia 2003;10(19):12-19.

  10. Hom DB, Linzie BM, Huang TC. The healing effects of autologous platelet gel on acute human skin wounds. Arch Facial Plast Surg 2007;9:174-183.




2020     |     www.medigraphic.com